118 related articles for article (PubMed ID: 23334067)
1. Short-term safety of pulse steroid therapy in multiple sclerosis relapses.
Shaygannejad V; Ashtari F; Alinaghian M; Norouzi R; Salari M; Fatehi F
Clin Neuropharmacol; 2013; 36(1):1-3. PubMed ID: 23334067
[TBL] [Abstract][Full Text] [Related]
2. Short-term combination of glatiramer acetate with i.v. steroid treatment preceding treatment with GA alone assessed by MRI-disease activity in patients with relapsing-remitting multiple sclerosis.
De Stefano N; Filippi M; Hawkins C;
J Neurol Sci; 2008 Mar; 266(1-2):44-50. PubMed ID: 17897678
[TBL] [Abstract][Full Text] [Related]
3. [Steroid therapy for multiple sclerosis].
Oishi C; Sakuta M
Nihon Rinsho; 2003 Aug; 61(8):1361-6. PubMed ID: 12962024
[TBL] [Abstract][Full Text] [Related]
4. Short-term effects of methylprednisolone on cerebral volume in multiple sclerosis relapses.
Chapman C; Tubridy N; Cook MJ; Mitchell PJ; MacGregor LR; Lovelock C; Litewka L; Sedal L; Kilpatrick TJ; Butzkueven H
J Clin Neurosci; 2006 Jul; 13(6):636-8. PubMed ID: 16790352
[TBL] [Abstract][Full Text] [Related]
5. Effect of high-dose intravenous methyl-prednisolone treatment on intraocular pressure in multiple sclerosis patients with relapse.
Acar M; Gedizlioglu M; Koskderelioglu A; Ozturk F; Kilinc S; Talay N
Eur Neurol; 2012; 68(1):20-2. PubMed ID: 22677889
[TBL] [Abstract][Full Text] [Related]
6. Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.
Then Bergh F; Kümpfel T; Schumann E; Held U; Schwan M; Blazevic M; Wismüller A; Holsboer F; Yassouridis A; Uhr M; Weber F; Daumer M; Trenkwalder C; Auer DP
BMC Neurol; 2006 May; 6():19. PubMed ID: 16719908
[TBL] [Abstract][Full Text] [Related]
7. Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis.
Vasheghani-Farahani A; Sahraian MA; Darabi L; Aghsaie A; Minagar A
J Neurol Sci; 2011 Oct; 309(1-2):75-8. PubMed ID: 21831398
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.
Zivadinov R; Zorzon M; De Masi R; Nasuelli D; Cazzato G
J Neurol Sci; 2008 Apr; 267(1-2):28-35. PubMed ID: 17945260
[TBL] [Abstract][Full Text] [Related]
9. Management of worsening multiple sclerosis with mitoxantrone: a review.
Fox EJ
Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
[TBL] [Abstract][Full Text] [Related]
10. Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses.
Ferraro D; Mirante VG; Losi L; Villa E; Simone AM; Vitetta F; Federzoni L; Nichelli PF; Sola P
Neurologist; 2015 Jun; 19(6):153-4. PubMed ID: 26075468
[TBL] [Abstract][Full Text] [Related]
11. Home administration of intravenous methylprednisolone for multiple sclerosis relapses: the experience of French multiple sclerosis networks.
Créange A; Debouverie M; Jaillon-Rivière V; Taithe F; Liban D; Moutereau A; Clavelou P; Defer G
Mult Scler; 2009 Sep; 15(9):1085-91. PubMed ID: 19556312
[TBL] [Abstract][Full Text] [Related]
12. Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis.
Zivadinov R; Dwyer MG; Hussein S; Carl E; Kennedy C; Andrews M; Hojnacki D; Heininen-Brown M; Willis L; Cherneva M; Bergsland N; Weinstock-Guttman B
Mult Scler; 2012 Aug; 18(8):1125-34. PubMed ID: 22194217
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse.
Jongen PJ; Stavrakaki I; Voet B; Hoogervorst E; van Munster E; Linssen WH; Sinnige LG; Verhagen WI; Visser LH; van der Kruijk R; Verheul F; Boringa J; Heerings M; Gladdines W; Lönnqvist F; Gaillard P
J Neurol; 2016 Aug; 263(8):1641-51. PubMed ID: 27272956
[TBL] [Abstract][Full Text] [Related]
14. [Change of interleukin-4 and interleukin-12 levels after therapy of multiple sclerosis relapse with methylprednisolone].
Bartosik-Psujek H; Magryś A; Montewka-Kozioł M; Stelmasiak Z
Neurol Neurochir Pol; 2005; 39(3):207-12. PubMed ID: 15981158
[TBL] [Abstract][Full Text] [Related]
15. The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment.
Lindquist S; Hassinger S; Lindquist JA; Sailer M
Mult Scler; 2011 Jul; 17(7):851-66. PubMed ID: 21561957
[TBL] [Abstract][Full Text] [Related]
16. Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis.
Cohen-Cymberknoh M; Blau H; Shoseyov D; Mei-Zahav M; Efrati O; Armoni S; Kerem E
J Cyst Fibros; 2009 Jul; 8(4):253-7. PubMed ID: 19447081
[TBL] [Abstract][Full Text] [Related]
17. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
Moreira MA; Tilbery CP; Monteiro LP; Teixeira MM; Teixeira AL
Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033
[TBL] [Abstract][Full Text] [Related]
18. Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy.
Schocke MF; Berger T; Felber SR; Wolf C; Deisenhammer F; Kremser C; Seppi K; Aichner FT
Neuroimage; 2003 Oct; 20(2):1253-63. PubMed ID: 14568494
[TBL] [Abstract][Full Text] [Related]
19. [Randomized controlled trial of high-dose peroral methylprednisolone in attacks of multiple sclerosis].
Sellebjerg F; Frederiksen JL; Nielsen PM; Olesen J
Ugeskr Laeger; 1999 Nov; 161(48):6625-9. PubMed ID: 10643347
[TBL] [Abstract][Full Text] [Related]
20. Recurrent atrial fibrillation after pulse corticosteroid treatment for a relapse of multiple sclerosis.
Pavičić T; Ruška B; Adamec I; Habek M
Mult Scler Relat Disord; 2019 Jul; 32():30-32. PubMed ID: 31029055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
